sr141716 has been researched along with Curling Ulcer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croci, T; Galzin, AM; Landi, M; Marini, P | 1 |
1 other study(ies) available for sr141716 and Curling Ulcer
| Article | Year |
|---|---|
Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents.
Topics: Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Duodenal Ulcer; Duodenitis; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Tumor Necrosis Factor-alpha | 2003 |